UK markets closed

Werewolf Therapeutics, Inc. (HOWL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.1400+0.0800 (+3.88%)
At close: 01:00PM EDT
2.1799 +0.04 (+1.86%)
After hours: 03:44PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-41,579
-37,368
-53,810
-49,983
-15,040
-
Depreciation & amortisation
1,803
1,764
1,104
216
150
-
Stock-based compensation
8,205
8,008
7,400
4,095
632
-
Change in working capital
-8,398
-5,894
2,539
2,277
2,308
-
Accounts payable
-7,707
-4,335
3,046
1,007
388
-
Other working capital
-38,723
-33,381
-44,207
-43,374
-19,184
-
Other non-cash items
1,958
878
2,164
519
627
-
Net cash provided by operating activities
-38,011
-32,612
-40,596
-42,876
-18,624
-
Cash flows from investing activities
Investments in property, plant and equipment
-712
-769
-3,611
-498
-560
-
Net cash used for investing activities
-712
-769
-3,611
-498
-560
-
Cash flows from financing activities
Common stock issued
29,953
18,329
15,740
111,600
0
-
Other financing activities
-
-
-88
-2,378
-339
-193
Net cash used provided by (used for) financing activities
30,065
58,429
15,906
109,427
93,857
-
Net change in cash
-8,658
25,048
-28,301
66,053
74,673
-
Cash at beginning of period
169,086
130,529
158,830
92,777
18,104
-
Cash at end of period
160,428
155,577
130,529
158,830
92,777
-
Free cash flow
Operating cash flow
-38,011
-32,612
-40,596
-42,876
-18,624
-
Capital expenditure
-712
-769
-3,611
-498
-560
-
Free cash flow
-38,723
-33,381
-44,207
-43,374
-19,184
-